U.S. Pharma Stock News

How Park Hotels & Resorts stock looks after recent performance Park Hotels & Resorts (PK) has seen mixed returns recently, with a 2.5% move over the past month and a small gain over the past 3 months, alongside a negative 1 year total return. For income focused investors, it is also worth noting that Park operates as a lodging REIT. It holds 38 premium branded hotels and resorts with more than 24,000 rooms concentrated in city center and resort locations. See our latest analysis for Park...

Dell Technologies (DELL) has drawn fresh attention after recent share price weakness, with the stock down about 11% over the past month and 25% over the past 3 months from its last close near $123.93. See our latest analysis for Dell Technologies. Set against this recent weakness, Dell Technologies’ 1 year total shareholder return of 4.05% and very large 3 and 5 year total shareholder returns show longer term holders have still seen substantial value creation. At the same time, shorter term...

Borr Drilling Limited recently announced new contract commitments for its premium jack-up rigs Ran and Odin in the Americas, including a one-well extension with ENI in Mexico and a multi-well deal in the United States that extends firm work visibility into 2026 and activates additional option periods into 2027. These contracts deepen Borr Drilling’s backlog and lengthen revenue visibility, particularly through the activated six-month optional period for Odin’s customer Cantium starting in...

Why Starbucks is back in focus Starbucks (SBUX) is drawing fresh attention after a flurry of consumer facing moves, including a MrBeast marketing tie up, renewed inclusion in Disney park dining plans, and an ongoing overhaul of its North American store footprint. See our latest analysis for Starbucks. The recent MrBeast tie in, Disney Dining Plan return and North American store reshaping come as Starbucks’ 90 day share price return of 11.77% outpaces its 1 year total shareholder return...

Eaton was recently downgraded by UBS from Buy to Neutral, with the bank citing limited room for earnings upgrades and pressure on future operating margins as the company continues capacity expansions tied to AI and data center demand. While analysts broadly still rate Eaton as Outperform and point to strong revenue growth and profitability, the UBS downgrade has sharpened focus on how ongoing investment and expansion could influence the balance between growth and margins over the next few...

PENGUIN SOLUTIONS, Inc. recently reported Q4 2025 results with flat year-on-year revenue of US$343.1 million, beating profit expectations and reaffirming full-year 2026 earnings guidance, including a 6% net sales growth outlook and an Adjusted EPS target of US$2 at the midpoint. Management’s ability to exceed profit forecasts while holding guidance steady and reducing Days Inventory Outstanding from 96 to 79 highlights tighter operational control during a pause in top-line expansion. We’ll...

Cognizant Technology Solutions (NASDAQ:CTSH) has had a great run on the share market with its stock up by a significant...

The fact that multiple RB Global, Inc. ( NYSE:RBA ) insiders offloaded a considerable amount of shares over the past...

Key Insights Significantly high institutional ownership implies Reliance's stock price is sensitive to their trading...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...

On January 5, 2026, Okta, Inc. announced that its board approved a share repurchase program of up to US$1.00 billion of Class A common stock, funded by existing cash and cash flow from operations with no fixed expiration date. The buyback authorization signals management’s conviction that Okta’s business outlook is strong and that its shares are trading below internal value estimates. Next, we’ll examine how Okta’s US$1.00 billion buyback plan may influence its investment narrative around...

Medtronic (MDT) is back on investor radar after William Blair upgraded the stock to Outperform, highlighting fresh product catalysts related to its Hugo robotic surgery platform and Symplicity Spyral renal denervation system. See our latest analysis for Medtronic. That upgrade comes on the back of a 1-year total shareholder return of 29.55% and a 3-year total shareholder return of 40.22%. The share price, now at $100.31, has seen momentum pick up again recently after some shorter term...

Why Acushnet Holdings is on investor watchlists today Acushnet Holdings (GOLF) has drawn attention after recent share price gains, with the stock up over the past week, month, and past 3 months, prompting fresh interest in how the business is currently valued. See our latest analysis for Acushnet Holdings. The recent 1-day share price return of 2.70% and 7-day share price return of 5.97% sit alongside a 1-year total shareholder return of 22.97% and 5-year total shareholder return of 119.80%...

Recent government contracts that helped Planet Labs PBC (PL) reach record fiscal third quarter revenue of $81.3 million have drawn investor attention, as has a pre-arranged share sale by co-founder Robert Schingler. See our latest analysis for Planet Labs PBC. Against this backdrop, Planet Labs PBC’s recent government contract wins and record quarterly revenue have coincided with a sharp acceleration in momentum, with a 71.03% 30 day share price return and a very large 1 year total...

If you are wondering whether DENTSPLY SIRONA is priced attractively right now, this article walks through what the current share price could mean for long term investors. The stock most recently closed at US$12.37, with returns of 8.5% over 7 days, 10.0% over 30 days, 9.8% year to date, but a 30.3% decline over 1 year, a 59.4% decline over 3 years and a 77.0% decline over 5 years. These figures have put valuation and expectations for DENTSPLY SIRONA back in focus for many investors and...

Morgan Stanley (MS) has filed to launch Bitcoin and Solana exchange traded funds, stepping directly into crypto products under its own brand and giving investors a fresh way to access regulated digital asset exposure. See our latest analysis for Morgan Stanley. The crypto ETF filings come after a period of strong momentum for Morgan Stanley, with a 90 day share price return of 20.62% and a 1 year total shareholder return of 52.12%, pointing to building interest in the stock over both shorter...

To the annoyance of some shareholders, Viomi Technology Co., Ltd ( NASDAQ:VIOT ) shares are down a considerable 26% in...

Why DigitalBridge Group Is On Investors’ Radar DigitalBridge Group (DBRG) has recently drawn attention after a period of mixed share performance, including a small 1 day move and stronger figures over the past month and past 3 months. Investors are weighing these returns against fundamentals and valuation. See our latest analysis for DigitalBridge Group. Set against a largely flat year to date share price return, DigitalBridge Group’s 30 day and 90 day share price returns of 8.78% and 29.95%...

Intuit (INTU) has drawn investor attention after recent trading left the shares with a return of about 3% year to date, while the 1 year total return sits near 6%. This has prompted fresh questions about valuation. See our latest analysis for Intuit. Intuit’s share price, now at $647.2, has a 7 day share price return of a 3.39% decline and a 30 day share price return of a 3.92% decline, while its 5 year total shareholder return of 82.34% points to momentum built over a longer horizon. If...

If you are wondering whether Aflac's current share price offers good value or is starting to look expensive, you are not alone. Aflac recently closed at US$111.96, with returns of 1.0% over the last 7 days, 2.5% over 30 days, 1.6% year to date, 11.3% over 1 year, 66.1% over 3 years and 172.3% over 5 years. This naturally raises questions about what is already priced in. Recent headlines around Aflac have focused on its position as a major US insurance name and ongoing interest from investors...

Key Insights The projected fair value for Sleep Number is US$14.44 based on 2 Stage Free Cash Flow to Equity Sleep...

If you are wondering whether AT&T's share price lines up with its fundamentals, this article walks through the key numbers so you can judge the value case for yourself. AT&T's stock last closed at US$24.34, with a 7 day return of 1.9% decline, a 30 day return of 3.7% decline, a year to date return of 0.9% decline, and a 1 year return of 14.5%. Over longer periods, the stock shows a 3 year return of 45.9% and a 5 year return of 49.5%, which helps frame how the current price sits against past...

Event context and recent performance AZZ (AZZ) has drawn fresh attention after its recent trading performance, with the share price at $110.42 and returns of 5% over the past month and 4.2% over the past 3 months. See our latest analysis for AZZ. Looking beyond the recent move, AZZ’s 1 year total shareholder return of 31.36% and 3 year total shareholder return of 153.69% suggest momentum has been building over a longer horizon, even as the latest 1 day share price return was slightly...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...